Literature DB >> 19277021

Functional cone rescue by RdCVF protein in a dominant model of retinitis pigmentosa.

Ying Yang1, Saddek Mohand-Said, Aude Danan, Manuel Simonutti, Valérie Fontaine, Emmanuelle Clerin, Serge Picaud, Thierry Léveillard, José-Alain Sahel.   

Abstract

In retinitis pigmentosa (RP), a majority of causative mutations affect genes solely expressed in rods; however, cone degeneration inevitably follows rod cell loss. Following transplantation and in vitro studies, we demonstrated the role of photoreceptor cell paracrine interactions and identified a Rod-derived Cone Viability Factor (RdCVF), which increases cone survival. In order to establish the clinical relevance of such mechanism, we assessed the functional benefit afforded by the injection of this factor in a frequent type of rhodopsin mutation, the P23H rat. In this model of autosomal dominant RP, RdCVF expression decreases in parallel with primary rod degeneration, which is followed by cone loss. RdCVF protein injections induced an increase in cone cell number and, more important, a further increase in the corresponding electroretinogram (ERG). These results indicate that RdCVF can not only rescue cones but also preserve significantly their function. Interestingly, the higher amplitude of the functional versus the survival effect of RdCVF on cones indicates that RdCVF is acting more directly on cone function. The demonstration at the functional level of the therapeutic potential of RdCVF in the most frequent of dominant RP mutations paves the way toward the use of RdCVF for preserving central vision in many RP patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19277021      PMCID: PMC2835133          DOI: 10.1038/mt.2009.28

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  50 in total

1.  The status of cones in the rhodopsin mutant P23H-3 retina: light-regulated damage and repair in parallel with rods.

Authors:  Vicki Chrysostomou; Jonathan Stone; Sally Stowe; Nigel L Barnett; Krisztina Valter
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03       Impact factor: 4.799

2.  Correlation between retinal sensitivity and photoreceptor inner/outer segment junction in patients with retinitis pigmentosa.

Authors:  Y Mitamura; S Aizawa; T Baba; A Hagiwara; S Yamamoto
Journal:  Br J Ophthalmol       Date:  2009-01       Impact factor: 4.638

3.  Disease-associated variants of the rod-derived cone viability factor (RdCVF) in Leber congenital amaurosis. Rod-derived cone viability variants in LCA.

Authors:  Sylvain Hanein; Isabelle Perrault; Sylvie Gerber; Hélène Dollfus; Jean-Louis Dufier; Josué Feingold; Arnold Munnich; Shomi Bhattacharya; Josseline Kaplan; José-Alain Sahel; Jean-Michel Rozet; Thierry Leveillard
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

Review 4.  Retinal degenerations: from cell signaling to cell therapy; pre-clinical and clinical issues.

Authors:  Thérese Cronin; Thierry Léveillard; José-Alain Sahel
Journal:  Curr Gene Ther       Date:  2007-04       Impact factor: 4.391

5.  Molecular and cellular alterations induced by sustained expression of ciliary neurotrophic factor in a mouse model of retinitis pigmentosa.

Authors:  Kun Do Rhee; Alberto Ruiz; Jacque L Duncan; William W Hauswirth; Matthew M Lavail; Dean Bok; Xian-Jie Yang
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

6.  Thioredoxin-like 6 protects retinal cell line from photooxidative damage by upregulating NF-kappaB activity.

Authors:  Xiao Wei Wang; Bao Zhen Tan; Miao Sun; Bow Ho; Jeak Ling Ding
Journal:  Free Radic Biol Med       Date:  2008-04-26       Impact factor: 7.376

7.  Effect of gene therapy on visual function in Leber's congenital amaurosis.

Authors:  James W B Bainbridge; Alexander J Smith; Susie S Barker; Scott Robbie; Robert Henderson; Kamaljit Balaggan; Ananth Viswanathan; Graham E Holder; Andrew Stockman; Nick Tyler; Simon Petersen-Jones; Shomi S Bhattacharya; Adrian J Thrasher; Fred W Fitzke; Barrie J Carter; Gary S Rubin; Anthony T Moore; Robin R Ali
Journal:  N Engl J Med       Date:  2008-04-27       Impact factor: 91.245

8.  Safety and efficacy of gene transfer for Leber's congenital amaurosis.

Authors:  Albert M Maguire; Francesca Simonelli; Eric A Pierce; Edward N Pugh; Federico Mingozzi; Jeannette Bennicelli; Sandro Banfi; Kathleen A Marshall; Francesco Testa; Enrico M Surace; Settimio Rossi; Arkady Lyubarsky; Valder R Arruda; Barbara Konkle; Edwin Stone; Junwei Sun; Jonathan Jacobs; Lou Dell'Osso; Richard Hertle; Jian-xing Ma; T Michael Redmond; Xiaosong Zhu; Bernd Hauck; Olga Zelenaia; Kenneth S Shindler; Maureen G Maguire; J Fraser Wright; Nicholas J Volpe; Jennifer Wellman McDonnell; Alberto Auricchio; Katherine A High; Jean Bennett
Journal:  N Engl J Med       Date:  2008-04-27       Impact factor: 91.245

9.  Stimulation of the insulin/mTOR pathway delays cone death in a mouse model of retinitis pigmentosa.

Authors:  Claudio Punzo; Karl Kornacker; Constance L Cepko
Journal:  Nat Neurosci       Date:  2008-12-07       Impact factor: 24.884

10.  Rod-derived Cone Viability Factor-2 is a novel bifunctional-thioredoxin-like protein with therapeutic potential.

Authors:  Frédéric Chalmel; Thierry Léveillard; Céline Jaillard; Aurélie Lardenois; Naomi Berdugo; Emmanuelle Morel; Patrice Koehl; George Lambrou; Arne Holmgren; José A Sahel; Olivier Poch
Journal:  BMC Mol Biol       Date:  2007-08-31       Impact factor: 2.946

View more
  73 in total

Review 1.  Retinal light damage: mechanisms and protection.

Authors:  Daniel T Organisciak; Dana K Vaughan
Journal:  Prog Retin Eye Res       Date:  2009-12-03       Impact factor: 21.198

2.  Chapter 6 - Restoring Vision to the Blind: Neuroprotection.

Authors: 
Journal:  Transl Vis Sci Technol       Date:  2014-12-30       Impact factor: 3.283

3.  Exploiting metabolic and antioxidant pathways to maintain vision in blinding disease.

Authors:  Pavitra S Ramachandran; Ji Yun Song; Jean Bennett
Journal:  J Clin Invest       Date:  2015-03-23       Impact factor: 14.808

Review 4.  Functional rescue of cone photoreceptors in retinitis pigmentosa.

Authors:  José-Alain Sahel; Thierry Léveillard; Serge Picaud; Deniz Dalkara; Katia Marazova; Avinoam Safran; Michel Paques; Jens Duebel; Botond Roska; Saddek Mohand-Said
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-07       Impact factor: 3.117

Review 5.  Let There Be Light: Gene and Cell Therapy for Blindness.

Authors:  Deniz Dalkara; Olivier Goureau; Katia Marazova; José-Alain Sahel
Journal:  Hum Gene Ther       Date:  2016-02       Impact factor: 5.695

6.  Autophagy-mediated catabolism of visual transduction proteins prevents retinal degeneration.

Authors:  Jingyu Yao; Lin Jia; Kecia Feathers; Chengmao Lin; Naheed W Khan; Daniel J Klionsky; Thomas A Ferguson; David N Zacks
Journal:  Autophagy       Date:  2016-10-18       Impact factor: 16.016

7.  Expression characteristics of dual-promoter lentiviral vectors targeting retinal photoreceptors and Müller cells.

Authors:  Susan L Semple-Rowland; William E Coggin; Mero Geesey; Kristofer S Eccles; Leah Abraham; Krunal Pachigar; Rachel Ludlow; Shahrokh C Khani; W Clay Smith
Journal:  Mol Vis       Date:  2010-05-27       Impact factor: 2.367

8.  Expression of rod-derived cone viability factor: dual role of CRX in regulating promoter activity and cell-type specificity.

Authors:  Sophie Lambard; Sacha Reichman; Cynthia Berlinicke; Marie-Laure Niepon; Olivier Goureau; José-Alain Sahel; Thierry Léveillard; Donald J Zack
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

9.  Transplantation of photoreceptor and total neural retina preserves cone function in P23H rhodopsin transgenic rat.

Authors:  Ying Yang; Saddek Mohand-Said; Thierry Léveillard; Valérie Fontaine; Manuel Simonutti; José-Alain Sahel
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

10.  Retinitis pigmentosa and allied conditions today: a paradigm of translational research.

Authors:  Carmen Ayuso; Jose M Millan
Journal:  Genome Med       Date:  2010-05-27       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.